Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL
Official Title: A Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of STAR-0215 in Participants With Heredit
Brief Summary: The goal of this clinical trial is to test the drug STAR-0215 in participants with hereditary angioedema (HAE).
One group of participants will get 1 dose of STAR-0215, and two other groups will get 2 doses of STAR-0215.
Researchers will study the effects of STAR-0215 in participants with HAE as this is the first time that the drug has been given to participants with HAE.